Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USAHumansFemaleBone Density Conservation AgentsDenmarkAged
Treatment patterns of romosozumab in postmenopausal women with severe osteoporosis in Denmark: findings from the ROmosozumab in Scandinavia real-world Evidence Study (ROSES).
Bente L Langdahl, Mattias Lorentzon, Tove T Borgen, Estelle Bajtner, Tanja Kaarill, Cecilie Alstad, Alexander Rieem Dun, Mie Sisse Konradsen, Johan Liseth Hansen, Oskar Ström, Evangelos Tsitlakidis, Alireza Moayyeri
Published: 202610.1007/s00198-025-07756-y
Abstract
PURPOSE: To describe patient and prescriber characteristics and factors associated with utilization of romosozumab in Denmark. METHODS: This registry‑based Danish retrospective cohort study comprised females aged ≥ 50 receiving osteoporosis medicatio…
Preview only. Read the full abstract at the source